Are you questioning the validity of the clinical trial of ResAppDx which received regulatory approval and RAP is selling Disallowed and have hoodwink Pfizer??
Response No-vote letter update, page-45
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #